Female Reproductive System Carcinoma — Trials

Female Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,481 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 458
Recruiting: 230
Ph III recruiting: 25
Growth YoY: +35.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05949424	OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE)	unknown	Phase 4	30	University Medical Center GroningenOTHER	1	Nov 29, 2023	clinicaltrials
NCT05187208	PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer(POLO)	unknown	Phase 4	102	Seoul National University HospitalOTHER	0	Jan 26, 2022